Cancer Detection Recovered Following Pandemic Disruptions
However, in 2021, cancer incidence rates remained substantially depressed from expected rates in rural areas
AAO: Corneal Toxicity Reported With Mirvetuximab Soravtansine
Corneal toxicity not uncommon with MIRV treatment for primary gynecologic malignancies, usually resolves
FIT Completion, Yield Rates Similar in Those Aged 45 to 49 Versus 50 Years
For individuals aged 45 to 49 years, FIT completion slightly higher while FIT positivity slightly lower
IDSA: Antibiotics for Seven Days Feasible for Patients Hospitalized With Bloodstream Infections
Findings show similar 90-day mortality with seven or 14 days of treatment
Novel Imaging Technique Accurate for Detecting Clear-Cell Renal Cell Cancer
In a recent study, mean sensitivity was 85.5 percent and specificity 87 percent for detection of clear-cell renal cell carcinoma
Pembrolizumab Aids Survival With High-Risk Endometrial Cancer
Findings seen in combination with chemotherapy following surgery in patients with curative intent
Sensitivity Reduced on Low-Dose Pediatric CT Scans for Small Lung Nodules
Reduced detection on low-dose CT scans using CAD systems more pronounced for nodules measuring less than 5 mm
Measures of Social Support Linked to Cancer Screening
Those who report never/rarely versus always having social support may have lowest odds of screening
Breast Cancer Risk Elevated With Levonorgestrel-Releasing Intrauterine System Use
Excess risk of 14 per 10,000 women seen with zero to five years of LNG-IUS use
Excess Adiposity Plays Role in Postmenopausal HR-Positive Breast Cancer
Estimated burden of 19.9 percent reported for body mass index and 41.9 percent for Clínica Universidad de Navarra-Body Adiposity Estimator
